Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1795 1
1805 1
1806 1
1807 1
1810 1
1811 1
1819 1
1820 1
1830 1
1835 1
1840 1
1841 1
1842 4
1843 2
1844 2
1847 3
1848 6
1849 6
1850 3
1851 3
1852 4
1853 6
1855 2
1857 1
1858 3
1859 1
1861 1
1862 1
1864 1
1865 1
1866 2
1868 1
1869 1
1871 3
1873 3
1875 6
1876 1
1877 2
1878 3
1879 4
1880 5
1881 5
1882 1
1883 1
1884 2
1885 4
1886 3
1887 5
1888 1
1889 1
1890 4
1891 7
1892 3
1893 3
1894 6
1895 3
1896 8
1897 7
1898 8
1899 8
1900 4
1901 5
1902 8
1903 1
1904 3
1905 7
1906 9
1907 13
1908 17
1909 19
1910 13
1911 19
1912 19
1913 18
1914 24
1915 26
1916 32
1917 33
1918 29
1919 29
1920 44
1921 53
1922 58
1923 54
1924 60
1925 43
1926 47
1927 78
1928 54
1929 56
1930 50
1931 51
1932 51
1933 46
1934 39
1935 48
1936 39
1937 37
1938 45
1939 40
1940 47
1941 54
1942 34
1943 28
1944 40
1945 112
1946 219
1947 343
1948 358
1949 275
1950 334
1951 426
1952 363
1953 396
1954 417
1955 450
1956 404
1957 402
1958 428
1959 428
1960 450
1961 523
1962 567
1963 775
1964 1026
1965 1133
1966 1509
1967 1587
1968 1868
1969 1918
1970 1964
1971 2090
1972 2151
1973 2252
1974 2250
1975 4835
1976 4806
1977 4543
1978 4607
1979 4937
1980 5018
1981 5200
1982 5536
1983 6173
1984 6916
1985 6992
1986 7184
1987 7451
1988 8003
1989 9563
1990 9751
1991 9914
1992 10116
1993 10276
1994 10714
1995 10818
1996 11627
1997 11630
1998 12284
1999 12976
2000 14470
2001 15842
2002 16760
2003 17733
2004 20720
2005 23967
2006 25804
2007 26650
2008 27996
2009 29085
2010 30930
2011 32637
2012 34451
2013 36407
2014 38523
2015 39855
2016 40896
2017 42905
2018 46623
2019 49220
2020 55821
2021 61138
2022 62620
2023 62619
2024 28855

Text availability

Article attribute

Article type

Publication date

Search Results

1,019,072 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Labarraque's
Page 1
Biocompatible dialysis fluids for peritoneal dialysis.
Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y. Htay H, et al. Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3. Cochrane Database Syst Rev. 2018. PMID: 30362116 Free PMC article.
OBJECTIVES: This review aimed to look at the benefits and harms of biocompatible PD solutions in comparison to standard PD solutions in patients receiving PD. ...Overall, 29 studies (1971 participants) compared neutral pH, low GDP PD solution with conventiona …
OBJECTIVES: This review aimed to look at the benefits and harms of biocompatible PD solutions in comparison to standard PD solutio …
Stability of tacrolimus ophthalmic solution.
Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M. Ezquer-Garin C, et al. Am J Health Syst Pharm. 2017 Jul 1;74(13):1002-1006. doi: 10.2146/ajhp160169. Am J Health Syst Pharm. 2017. PMID: 28645998
PURPOSE: The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied. METHODS: A sterile ophthalmic solution of 0.3 mg/mL tacrolimus was prepared in triplicate under aseptic conditions by diluting tacrolimus in eye drops. …
PURPOSE: The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied. METHODS: A sterile …
[Gordeev's solution].
[No authors listed] [No authors listed] Feldsher Akush. 1951 Dec;12:50-1. Feldsher Akush. 1951. PMID: 14887762 Undetermined Language. No abstract available.
Application of solution calorimetry in pharmaceutical and biopharmaceutical research.
Royall PG, Gaisford S. Royall PG, et al. Curr Pharm Biotechnol. 2005 Jun;6(3):215-22. doi: 10.2174/1389201054022887. Curr Pharm Biotechnol. 2005. PMID: 15974976 Review.
In solution calorimetry the heat of solution (Delta(sol)H) is recorded as a solute (usually a solid) dissolves in an excess of solvent. ...Careful experimental design and data interpretation also allows the measurement of the enthalpy of transfer (Delta(trans …
In solution calorimetry the heat of solution (Delta(sol)H) is recorded as a solute (usually a solid) dissolves in an ex …
Formulation and Stability of Solutions.
Akers MJ. Akers MJ. Int J Pharm Compd. 2016 Mar-Apr;20(2):137-41. Int J Pharm Compd. 2016. PMID: 27326440
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to p …
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs for …
Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
Raut AS, Kalonia DS. Raut AS, et al. Mol Pharm. 2016 May 2;13(5):1431-44. doi: 10.1021/acs.molpharmaceut.5b00937. Epub 2016 Apr 5. Mol Pharm. 2016. PMID: 27017836 Review.
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be an indicator of the presence of aggregates or precursor to phase separation in solution signifying reduced product stability. ...The review also highlights pharmaceutical im …
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be an indicator of the presence of aggregates or p …
Characterization of pharmaceutical polymorphs by isothermal calorimetry.
Urakami K. Urakami K. Curr Pharm Biotechnol. 2005 Jun;6(3):193-203. doi: 10.2174/1389201054022904. Curr Pharm Biotechnol. 2005. PMID: 15974974 Review.
Hence it is essential to choose the most suitable polymorphic form in the early stage of pharmaceutical development. The following article reviews the recent applications of solution calorimetry that allows characterization of pharmaceutical polymorphs throug …
Hence it is essential to choose the most suitable polymorphic form in the early stage of pharmaceutical development. The following ar …
A modified Schiff's solution.
KASTEN FH, BURTON V. KASTEN FH, et al. Stain Technol. 1959 Sep;34:289. Stain Technol. 1959. PMID: 14404684 No abstract available.
1,019,072 results
You have reached the last available page of results. Please see the User Guide for more information.